Latest News about AVIR
Recent news which mentions AVIR
From Benzinga
Tickers
AVIR
From Motley Fool
Earnings Scheduled For March 30, 2021
March 30, 2021
From Benzinga
From Benzinga
From MarketWatch
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
Additional Preclinical Data For Atea Pharma's COVID-19 Antiviral Drug Candidate, Highlighted In Online Manuscript
February 09, 2021
Tickers
AVIR
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 03, 2021
From Benzinga
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 02, 2021
From Benzinga
88 Biggest Movers From Friday
February 01, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 29, 2021
From Benzinga
68 Stocks Moving In Friday's Mid-Day Session
January 29, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 29, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
These 2 Coronavirus Stocks Could Soar in the First Half of 2021
January 26, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
January 11, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
January 05, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
January 04, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.